Abstract
Background: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 110 million individuals and led to 2.5 million deaths worldwide. As more individuals are vaccinated, the clinical performance and utility of SARS-CoV-2 serology platforms needs to be evaluated.
Methods: The ability of 4 commercial SARS-CoV-2 serology platforms to detect previous infection or vaccination were evaluated using a cohort of 53 patients who were SARS-CoV-2 PCR positive, 89 SARS-CoV-2-vaccinated healthcare workers (Pfizer or Moderna), and 127 patients who were SARS-CoV-2 negative. Serology results were compared to a cell-based SARS-CoV-2 pseudovirus (PSV) neutralizing antibodies assay.
Results: The Roche S-(spike) antibody and Diazyme neutralizing antibodies (NAbs) assays detected adaptive immune response in 100.0% and 90.1% of vaccinated individuals who received 2 doses of vaccine (initial and booster), respectively. The Roche N-(nucleocapsid) antibody assay and Diazyme IgG assay did not detect adaptive immune response in vaccinated individuals. The Diazyme NAbs assay correlated with the PSV SARS-CoV-2 median infective dose (ID50) neutralization titers (R2 = 0.70), while correlation of the Roche S-antibody assay was weaker (R2 = 0.39). Median PSV SARS-CoV-2 ID50 titers more than doubled in vaccinated individuals who received 2 doses of the Moderna vaccine (ID50, 597) compared to individuals who received a single dose (ID50, 284).
Conclusions: The Roche S-antibody and Diazyme NAbs assays robustly detected adaptive immune responses in SARS-CoV-2 vaccinated individuals and SARS-CoV-2 infected individuals. The Diazyme NAbs assay strongly correlates with the PSV SARS-CoV-2 NAbs in vaccinated individuals. Understanding the reactivity of commercially available serology platforms is important when distinguishing vaccination response versus natural infection.
Keywords: COVID-19; SARS-CoV-2; commercial assays; neutralizing antibodies; serology; vaccines.
【저자키워드】 COVID-19, SARS-CoV-2, Neutralizing antibodies, serology, Vaccines., commercial assays, 【초록키워드】 neutralizing antibody, IgG, Vaccine, immune response, vaccination, Vaccines, Neutralizing antibodies, serology, antibody, Infection, severe acute respiratory syndrome Coronavirus, healthcare worker, Pfizer, Severe acute respiratory syndrome, Cohort, pseudovirus, immune responses, Patient, death, understanding, Neutralizing, SARS-CoV-2 pseudovirus, Adaptive immune response, respiratory, correlation, utility, natural infection, Roche, platform, booster, Infective dose, single dose, Moderna, NAb, neutralization titers, Coronavirus-2, dose, adaptive immune responses, SARS-CoV-2 PCR, acute respiratory syndrome, acute respiratory syndrome coronavirus, SARS-CoV-2 infected individuals, infected individuals, individual, NAbs, acute respiratory syndrome coronavirus-2, vaccinated individuals, positive, neutralization titer, vaccinated individual, infective, initial, detect, evaluated, median, correlated, reactivity, PSV, SARS-CoV-2 NAb, 【제목키워드】 response, status,